# FDA Approves Sandoz Generic Drug Application Sandoz has received FDA approval for its abbreviated new drug application (ANDA 212068), expanding the company's generic portfolio and positioning it to capture additional market share in the competitive generic pharmaceuticals sector. The approval strengthens Sandoz's ability to offer cost-effective therapeutic alternatives to healthcare providers and patients.